Bruton tyrosine kinase
| GO Term | Evidence Code | PMID |
|---|---|---|
| neutrophil homeostasis | ||
| positive regulation of type III hypersensitivity | ||
| positive regulation of type I hypersensitivity | ||
| adaptive immune response | ||
| adaptive immune response |
| GO Term | Evidence Code | PMID |
|---|---|---|
| protein tyrosine kinase activity | ||
| protein tyrosine kinase activity | ||
| protein tyrosine kinase activity | ||
| non-membrane spanning protein tyrosine kinase activity | ||
| non-membrane spanning protein tyrosine kinase activity |
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:0050746 | mantle cell lymphoma | |
| DOID:0060875 | isolated growth hormone deficiency type III | |
| DOID:14179 | X-linked agammaglobulinemia | |
| DOID:2583 | agammaglobulinemia | |
| DOID:3234 | central nervous system lymphoma | |
| DOID:707 | B-cell lymphoma | |
| DOID:8584 | Burkitt lymphoma |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.4.0
Last updated: December 8, 2025